16/02/2026
current research suggests that honey does not increase cancer growth; in fact, numerous studies indicate it may have anti-cancer properties and can help reduce the side effects of conventional cancer treatments.
While cancer cells consume a lot of glucose (a primary sugar in honey), the overall effects of honey are complex and appear to be beneficial due to its rich composition of over 200 compounds, including flavonoids and phenolic acids.
Key Findings from Research
Anti-proliferative effects: Studies in cell cultures and animal models have shown that various types of honey can inhibit the proliferation and growth of cancer cells, including those from breast, colon, liver, and prostate cancers.
Induction of Apoptosis: Honey has been found to induce apoptosis (programmed cell death) in cancer cells while being non-toxic to normal cells.
Anti-inflammatory and Antioxidant Properties: Chronic inflammation and oxidative stress are risk factors for cancer development. The high antioxidant and anti-inflammatory content of honey helps to mitigate these factors by scavenging free radicals and modulating inflammatory pathways.
Synergy with Treatments: Some studies suggest honey may enhance the effectiveness of chemotherapy drugs like tamoxifen and 5-fluorouracil, and help manage treatment-related side effects such as oral mucositis.
Important Considerations
Most research on honey's anti-cancer effects has been conducted in laboratory (in vitro) and animal (in vivo) models.
The composition and potency of honey vary significantly depending on its floral and geographical origin.
While honey contains sugar, its complex composition distinguishes its effects from refined, added sugars, which are generally recommended to be limited in a cancer-preventive diet.
Clinical trials in humans are still limited, and more research is needed before honey can be recommended as a standalone cancer treatment. It is currently being explored as a potential complementary agent in integrati
